Postmarketing drug surveillance and death by committee

被引：1
|
作者：
Lyles, Alan
机构：
来源：
CLINICAL THERAPEUTICS | 2006年 / 28卷 / 06期
关键词：
D O I：
10.1016/j.clinthera.2006.06.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：962 / 963
页数：2
相关论文
共 50 条
  • [31] Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
    Marianne Gex-Fabry
    Luc P. Balant
    Androniki E. Balant-Gorgia
    [J]. Drug Safety, 2001, 24 : 947 - 959
  • [32] Active Postmarketing Drug Surveillance for Multiple Adverse Events
    Goh, Joel
    Bjarnadottir, Margret V.
    Bayati, Mohsen
    Zenios, Stefanos A.
    [J]. OPERATIONS RESEARCH, 2015, 63 (06) : 1528 - 1546
  • [33] US FDA addresses postmarketing drug surveillance concerns
    [J]. Reactions Weekly, 2004, 1030 (1) : 3 - 3
  • [34] Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions
    Gex-Fabry, M
    Balant-Gorgia, AE
    Balant, LP
    [J]. DRUG SAFETY, 2001, 24 (13) : 947 - 959
  • [35] US FDA Enhancing Postmarketing Drug Safety Surveillance
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
  • [36] POSTMARKETING DRUG SURVEILLANCE - DATA PRESENTATION AND ELEMENTS FOR A DECISION
    LAGIER, G
    [J]. REVUE DE MEDECINE INTERNE, 1986, : 41 - 44
  • [37] An Evaluation of Drug-Ineffective Postmarketing Reports in Drug Safety Surveillance
    Misu, Takashi
    Kortepeter, Cindy
    Munoz, Monica
    Wu, Eileen
    Chung, Haemy
    Dal Pan, Gerald J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 324 - 324
  • [38] POSTMARKETING SURVEILLANCE
    VOSS, S
    HARRIS, F
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6948): : 194 - 194
  • [39] POSTMARKETING SURVEILLANCE
    DENES, G
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (23): : 373 - 375
  • [40] Scientific challenges in postmarketing surveillance of ocular adverse drug reactions
    Fraunfelder, Frederick W.
    Fraunfelder, Frederick T.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (01) : 145 - 149
12345